Health & Fitness
Health and Fitness
Health and Fitness
Mon, August 8, 2011
Sun, August 7, 2011
Sat, August 6, 2011
Fri, August 5, 2011
Thu, August 4, 2011
Wed, August 3, 2011 Kahn Swick & Foti, LLC Announces Investigation into Dendreon Corp.
NEW ORLEANS--([ BUSINESS WIRE ])--The law firm of Kahn Swick & Foti, LLC (aKSFa) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., announce the commencement of an investigation into Dendreon Corp. (aDendreona or the Company)(Nasdaq: DNDN) to determine whether it has violated federal securities laws by issuing false and misleading statements to its shareholders.
Shares of Dendreon fell 62%, from $22.38 to $13.46 in aftermarket trading, after the Company announced that it was withdrawing its forecast of $350 million to $400 million in sales of its prostate cancer therapy Provenge a" its only marketed product a" because payers are uncertain about reimbursement for the costly treatment.
If you have information that would assist KSF in its investigation, or would like to discuss your legal rights, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn ([ lewis.kahn@ksfcounsel.com ]), toll free 1-877-515-1850, after hours via cell phone 504-301-7900.
About Kahn Swick & Foti, LLC
KSF is a law firm focused on securities class action and shareholder derivative litigation with offices in New York and Louisiana. For more information on KSF, please visit [ www.ksfcounsel.com ].
